Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-22

FDA Approved: LEVOLEUCOVORIN — Original Application (Meitheal Pharmaceuticals Inc)

View source ↗

Summary

FDA approved Meitheal Pharmaceuticals' levoleucovorin calcium as an original application (ANDA) for a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOLEUCOVORIN CALCIUM (LEVOLEUCOVORIN)

Snippet

ORIG AP for LEVOLEUCOVORIN (LEVOLEUCOVORIN CALCIUM)